✦ LIBER ✦

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

✍ Scribed by Loupakis, F.; Cremolini, C.; Salvatore, L.; Masi, G.; Sensi, E.; Schirripa, M.; Michelucci, A.; Pfanner, E.; Brunetti, I.; Lupi, C.; Antoniotti, C.; Bergamo, F.; Lonardi, S.; Zagonel, V.; Simi, P.; Fontanini, G.; Falcone, A.

Book ID: 121394447
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 651 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.08.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic and pharmacogenetic angi

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer

✍ Loupakis, F; Cremolini, C; Fioravanti, A; Orlandi, P; Salvatore, L; Masi, G; Di 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

6080 Reintroduction of FOLFOXIRI treatme

6080 Reintroduction of FOLFOXIRI treatment in metastatic colorectal cancer patients progressed after first-line FOLFOXIRI

✍ Vasile, E.; Masi, G.; Loupakis, F.; Cupini, S.; Baldi, G.G.; Salvatore, L.; Forn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

6060 KRAS and BRAF mutational analyses i

6060 KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)

✍ Salvatore, L.; Loupakis, F.; Fontanini, G.; Cremolini, C.; Stasi, I.; Fabbri, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Bevacizumab with FOLFOXIRI (irinotecan,

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

✍ Gianluca Masi; Fotios Loupakis; Lisa Salvatore; Lorenzo Fornaro; Chiara Cremolin 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 269 KB

6082 Second-line treatments in patients

6082 Second-line treatments in patients with metastatic colorectal cancer progressed after first-line FOLFOXIRI

✍ Masi, G.; Vasile, E.; Loupakis, F.; Fornaro, L.; Salvatore, L.; Cupini, S.; Stas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Capecitabine and bevacizumab as first-li

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB